lenalidomide
Not Tagged
[' lena', 'mmsm', 'lenalidomide', 'beyond,trial', 'congrat', 'myeloma xi']
top #ash22 presentation by on potential individualization of duration of maintenance in myeloma based on genetics and mrd
the 3 year landmark suggestion of stopping maintenance in mrd negative patients should be investigated and confirmed in trials. congratulations! #mmsm 
Director Flow Cytometry Core - CIMA LAB Diagnostics
Director Myeloma Laboratory - Clinica & CIMA Universidad de Navarra